Kiran Mazumdar-Shaw names Claire Mazumdar as Biocon successor

Kiran Mazumdar-Shaw has reportedly chosen her niece, Claire Mazumdar, founder and CEO of Bicara Therapeutics, to succeed her at Biocon.

5 May, 06:42 — 5 May, 06:42

Post Share

Sources

Showing 1 of 1 sources

Times of IndiaMostly Factual118d ago

Kiran Mazumdar-Shaw picks niece Claire Mazumdar as successor at Biocon: Report

Claire Mazumdar, 37 years of age, currently heads Bicara Therapeutics as its founder and CEO. The firm, which was incubated by Biocon and later listed on NASDAQ, went public in 2024 and now has a market valuation of over $1.6 billion.

By TOI BUSINESS DESK

Read full article →

Kiran Mazumdar-Shaw names Claire Mazumdar as Biocon successor

Sources

Kiran Mazumdar-Shaw picks niece Claire Mazumdar as successor at Biocon: Report

Related Stories

Corporate Earnings Reports Cover Patagonia Gold, Nordic Fibreboard, and Nutanix

Multiple Nations Adjust Retail Fuel Prices Amid Mixed Market Trends

India’s Economy Surges 7.8% Despite Middle East Tensions

Belgium Opposes Using Frozen Russian Assets for Ukrainian Support